The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.

CONCLUSIONS: We provide a comprehensive genomic landscape of MCC and demonstrate clinicogenomic associates of immunotherapy response. PMID: 31399473 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31399473?dopt=Abstract

Source: Clinical Cancer Research - August 8, 2019 Category: Cancer & Oncology Authors: Knepper TC, Montesion M, Russell J, Sokol ES, Frampton GM, Miller VA, Albacker LA, McLeod HL, Eroglu Z, Khushalani NI, Sondak VK, Messina JL, Schell MJ, DeCaprio JA, Tsai KY, Brohl AS Tags: Clin Cancer Res Source Type: research